恒瑞医药

600276 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

366.0B ($53.2B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

28.0B

Net Income

6.3B

Gross Margin

N/A

Op. Margin

26.8%

Net Margin

22.6%

ROE

13.7%

ROA

12.6%

D/E

0.09

Dividend Yield

N/A

EPS

1.00

Current Ratio

9.72

Price History

Company Info

Industry	C27医药制造业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2024
Website	www.hengrui.com

Business Overview

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 恒瑞医药

Ticker	600276
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业

Website

https://www.hengrui.com